Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers

International Journal of Clinical Pharmacology and Therapeutics

Volumn 47, Issue 6, 2009, Pages 413-418

  Chik, Zamri ^a   Basu, R C ^a   Pendek, R ^a   Lee, T C ^b   Mohamed, Z ^a  

^a UNIVERSITY OF MALAYSIA   (Malaysia)

^b SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Bioequivalence; GCMS; Salbutamol

Indexed keywords

BRETHMOL; GENERIC DRUG; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MASS FRAGMENTOGRAPHY; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 67649970602     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP47413     Document Type: Article

References (9)

1. Goldstein DA, Tan YK and Soldin SJ. Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers. Eur J Clin Pharmacol. 1987; 32: 631-634.
2. Nelson HS. β-Adrenergic Bronchodilators. N Engl J Med. 1995; 333: 499-507.
3. 2-adrenoceptor expression in human lung. Eur J Pharmacol 1996; 318: 123-129.
4. Ministry of Health Malaysia. Malaysian Guidelines for Good Clinical Practice; 1999.
5. Ministry of Health Malaysia. Malaysian Guidelines for The Conduct of Bioavailability and Bioequivalence Studies; 2000.
6. PDR®. Electronic Library. 59th Edition; 2005.
7. Schuirmann DJ. Acomparison of the two one-sided test procedures and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinetic Biopharm. 1987; 15: 657-680.
8. Steinijans VW, Diletti E. Statistical analysis of bioavailability studies; parametric and non parametric confidence intervals. Eur J Clin Pharmacol 1983; 24: 127-136.
9. U.S. Department of Health and Human Services Food and Drug Administration (FDA). Guidance For Industry Bioanalytical Method Validation. URL http://www.fda.gov/CDER/GUIDANCE/4252fnl.pdf; 2001.